Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers

Neuropsychopharmacology

Volumn 25, Issue 5, 2001, Pages 699-703

  Zwanzger, Peter ^a   Baghai, Thomas C ^a   Schuele, Cornelius ^a   Ströhle, Andreas ^b   Padberg, Frank ^a   Kathmann, Norbert ^a   Schwarz, Markus ^a   Möller, Hans Jürgen ^a   Rupprecht, Rainer ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

ACTH; Cholecystokinin tetrapeptide (CCK 4); Cortisol; GABA; HPA system; Panic attacks; Vigabatrin

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRATE AMINOTRANSFERASE INHIBITOR; 4 AMINOBUTYRIC ACID; CORTICOTROPIN; HYDROCORTISONE; PLACEBO; TETRAGASTRIN; VIGABATRIN;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG EFFECT; ENZYME INHIBITION; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PANIC; PRIORITY JOURNAL; RATING SCALE; TRANQUILIZING ACTIVITY;

4-AMINOBUTYRATE TRANSAMINASE; ADRENOCORTICOTROPIC HORMONE; ADULT; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ENZYME INHIBITORS; HUMANS; HYDROCORTISONE; MALE; PANIC; PSYCHIATRIC STATUS RATING SCALES; TETRAGASTRIN; VIGABATRIN;

EID: 0034784011     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00266-4     Document Type: Article

References (29)

1. Stimulation of corticotropin release by pentagastrin in normal subjects and patients with panic disorder
2. Pharmacokinetic effects of vigabatrin on cerebrospinal fluid amino acids in humans
3. Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones
4. Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients
5. The cholecystokinin hypothesis of anxiety and panic disorder
6. Dose ranging study of the effects of cholecystokinin in healthy volunteers
7. Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder
8. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings
9. Central benzodiazepine involvement in clonidine cardiovascular actions
10. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers
11. Effect of pentagastrin on adrenocorticotropin hormone and thyroid-stimulating hormone release in normal subjects
12. Measurement of lactate-induced panic and anxiety
13. A central gamma-aminobutyric mechanism in cardiac vagal control in man revealed by studies with intravenous midazolam
14. Neurohormonal responses to cholecystokinin tetrapeptide: A comparison of younger and older healthy subjects
15. New antiepileptic drugs
16. CCK in animal and human research on anxiety
17. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
18. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: A comparison of panickers and nonpanickers
19. A agonist THIP (gaboxadol) increases non-REM sleep and enhances delta activity in the rat
20. A controlled study of vigabatrin and visual abnormalities
21. Flumazenil provocation of panic attacks
22. Vigabatrin has an anxiolytic effect in the elevated plus-maze test of anxiety
23. Anxiolytic-like effect of the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA) on rat exploratory activity
24. Effect of the GABA-transaminase inhibitor vigabatrin on exploratory behaviour in socially isolated rats
25. Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder
26. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder
27. Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks
28. Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders
29. Anxiolytic effects of vigabatrin in panic disorder